Utah Medical Products, Inc. (NASDAQ:UTMD) CEO Kevin L. Cornwell sold 1,100 shares of the business’s stock in a transaction that occurred on Monday, March 12th. The stock was sold at an average price of $93.97, for a total value of $103,367.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Shares of Utah Medical Products, Inc. (NASDAQ UTMD) traded up $1.05 during midday trading on Wednesday, reaching $92.40. The company’s stock had a trading volume of 2,479 shares, compared to its average volume of 14,733. The firm has a market capitalization of $348.62, a P/E ratio of 40.02 and a beta of 0.77. Utah Medical Products, Inc. has a 1 year low of $58.50 and a 1 year high of $94.65.
Utah Medical Products (NASDAQ:UTMD) last announced its quarterly earnings results on Tuesday, January 30th. The medical instruments supplier reported $0.95 earnings per share for the quarter. The firm had revenue of $10.20 million for the quarter. Utah Medical Products had a return on equity of 18.85% and a net margin of 20.54%.
Several large investors have recently modified their holdings of the company. Teachers Advisors LLC boosted its holdings in shares of Utah Medical Products by 3.8% during the second quarter. Teachers Advisors LLC now owns 5,710 shares of the medical instruments supplier’s stock worth $413,000 after acquiring an additional 208 shares during the period. Northern Trust Corp boosted its holdings in shares of Utah Medical Products by 0.6% during the second quarter. Northern Trust Corp now owns 53,294 shares of the medical instruments supplier’s stock worth $3,858,000 after acquiring an additional 305 shares during the period. The Manufacturers Life Insurance Company boosted its holdings in shares of Utah Medical Products by 15.4% during the second quarter. The Manufacturers Life Insurance Company now owns 3,355 shares of the medical instruments supplier’s stock worth $242,000 after acquiring an additional 448 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of Utah Medical Products by 2.3% during the third quarter. JPMorgan Chase & Co. now owns 34,518 shares of the medical instruments supplier’s stock worth $2,577,000 after acquiring an additional 761 shares during the period. Finally, Wells Fargo & Company MN boosted its holdings in shares of Utah Medical Products by 4.4% during the fourth quarter. Wells Fargo & Company MN now owns 28,464 shares of the medical instruments supplier’s stock worth $2,317,000 after acquiring an additional 1,210 shares during the period. Institutional investors own 67.12% of the company’s stock.
Separately, BidaskClub raised Utah Medical Products from a “hold” rating to a “buy” rating in a research report on Wednesday, February 7th.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2018/03/14/kevin-l-cornwell-sells-1100-shares-of-utah-medical-products-inc-utmd-stock.html.
Utah Medical Products Company Profile
Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.